Story perspectives
CMS Halts Medicaid, CHIP Funding for Child Gender-Affirming Treatments
8/12/2026
1 of 1
Story summary
- CMS Administrator Dr. Mehmet Oz announced Medicaid will stop funding child sex-change hormones, puberty blockers, and surgeries.
- The rule also ends CHIP coverage of those treatments.
- Mental-health services for gender dysphoria stay covered by Medicaid and CHIP.
- HHS Secretary Robert F. Kennedy Jr. said the policy follows a safety-concern review, uses the United Kingdom’s 2024 Cass Review, and allows a six-month transition for children currently on hormones.
